UPB
Upstream Bio, Inc.
5.40$
+3.7%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | -4.8% | +107.0% | -5.3% | -7.8% | -7.0% | -9.6% | -10.1% | -11.6% | |
| – | – | – | – | -6.5% | +110.8% | -5.3% | -7.8% | -7.0% | -9.6% | -10.1% | -11.6% | |
| – | – | +325.1% | -56.9% | -30.4% | +889.1% | -78.1% | -36.3% | +58.7% | +40.8% | -4.8% | -17.9% | |
| – | – | +0.0% | +114.7% | -6.4% | +113.2% | -8.3% | -8.8% | -5.4% | -8.3% | -13.7% | -11.3% | |
| – | – | – | – | +20.4% | +8.1% | +47.3% | +52.1% | -74.2% | -2.2% | +54.8% | +107.9% | |
| – | – | -144.9% | – | +0.5% | -97.0% | -11.0% | +11.5% | +7.1% | +11.0% | +0.4% | -27.3% | |
| – | – | – | – | +6.1% | -1.3% | -10.9% | +14.2% | +9.0% | +13.0% | +1.6% | -26.9% | |
| – | – | – | – | – | +3.8% | +0.6% | +0.6% | +0.6% | +0.6% | +0.6% | +0.6% | |
| – | – | – | – | -11.9% | -17.5% | +16.8% | -45.9% | +54.9% | -31.0% | -37.3% | +35.3% | |
| – | – | – | -236.0% | – | – | -5.2% | -8.3% | -7.4% | -10.3% | -10.5% | -10.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +41.3% | +0.0% | +0.0% | +0.0% | +4.4% | +0.3% | +0.3% | +0.6% | +0.2% | +0.4% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.